You are here: Industry Insights > Treatment

News List

Fast Track designation given to heart failure treatment europeanpharmaceuticalreview
September 18, 2019
Farxiga (dapagliflozin) has been given Fast Track designation by the FDA to reduce the risk of cardiovascular death.
Radiation Rx Might Ease a Dangerous Irregular Heart Beat drugs
September 18, 2019
A new technique that uses a targeted high dose of radiation seems to prevent recurrence of a potentially deadly heartbeat for at least two years, researchers from Washington University School of Medicine in St. Louis report.
A promising treatment for an incurable, deadly kidney disease worldpharmanews
September 17, 2019
A potential treatment for polycystic kidney disease - a genetic disorder that causes the kidneys to swell with multiple cysts and can eventually lead to organ failure - has shown promising results in animal testing.
FDA grants regulatory approval for hypoglycemia treatment europeanpharmaceuticalreview
September 16, 2019
GVOKE injection has received regulatory approval from the FDA for the treatment of severe hypoglycemia in patients with diabetes.
Microrobot could be used to deliver hyperthermia treatment to cancers europeanpharmaceuticalreview
September 12, 2019
A team has developed a microrobot that is effective at targeting specific areas, so could be used in hyperthermia therapies when treating cancers.
What Works Best Against Varicose Veins? drugs
September 05, 2019
More than 40 million Americans suffer from varicose veins, which can be both unsightly and painful, but the best way to get rid of them hasn't been clear.
ADCendo secures loan to advance ADCs for cancer treatment pharmaceutical-technology
September 03, 2019
ADCendo has secured a loan amount to advance its novel antibody-drug conjugates (ADCs) that are being developed to treat cancers.
Researchers find new drug with promise for malaria treatment pharmaceutical-technology
September 03, 2019
An international research team led by the University of Glasgow has discovered a new drug that could kill the malaria-causing parasite, offering hope for the treatment of the disease.
Potential New Lupus Treatment Effectively Reduced Disease Activity in Trial americanpharmaceuticalreview
September 03, 2019
The Lupus Research Alliance has announced a potential new medicine for lupus, anifrolumab, reduced disease activity versus placebo in a second Phase III study.
Biologics and generics reported to save NHS £700m europeanpharmaceuticalreview
September 03, 2019
An NHS-wide plan to use more generic and biologic products has reportedly saved the healthcare provider £700 million since 2016.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page